Intracept Intraosseous Basivertebral Nerve Ablation
Launched by UNIVERSITY OF UTAH · Dec 13, 2022
Trial Information
Current as of July 03, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The Intracept clinical trial is studying the effectiveness and safety of a specific treatment for low back pain called the Intracept Procedure. This procedure involves targeting a nerve in the lower back to help reduce pain. The trial is collecting information from patients who have already undergone this treatment to understand how well it works for them and how satisfied they are with the results.
To participate in this study, individuals need to be scheduled for the Intracept Procedure or have already had it done for their low back pain. The trial is open to all adults between the ages of 65 and 74. Participants can expect to share their experiences and answer questions about their pain levels and overall satisfaction with the treatment. It’s important to note that this study is currently active but not looking for new participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients scheduled for intraosseous basivertebral nerve ablation with the Intracept Procedure
- • OR Participant had an Intracept Procedure for their low back pain and completed standard of care questionnaires at their procedure appointment.
- Exclusion Criteria:
- • Not scheduled for an intraosseous basivertebral nerve ablation with the Intracept Procedure
- • Intracept procedure for different location other than low back pain
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Farmington, Utah, United States
South Jordan, Utah, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials